RhumbLine Advisers
MDLN

RhumbLine Advisers’s Medline Inc MDLN Stock Holding History

RhumbLine Advisers’s Portfolio MDLN Stock Details MDLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17M Buy
430,245
+171,799
+66% +$6.92M 0.01% 839
2026
Q1 		$11.5M Buy
+258,446
New +$11.4M 0.01% 990

Other funds holding MDLN

CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
HFCIX
H&F Corporate Investors X San Francisco, California $2.8B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
ECU
Egerton Capital (UK) London, United Kingdom $10.4B AUM 25.66% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RhumbLine Advisers's MDLN Position: Q2 2026 in Review

RhumbLine Advisers increased its Medline Inc (MDLN) stake by 66% in Q2 2026, buying an estimated $6.92M and bringing the position to 430,245 shares worth $17M. The position accounts for 0.01% of the portfolio, ranked #839.

RhumbLine Advisers first reported a position in MDLN in Q1 2026 and has held it in 2 quarters since. 268 funds tracked by Wall St. Rank hold MDLN as of Q2 2026.

  • RhumbLine Advisers held 430,245 shares of Medline Inc worth $17M as of Q2 2026.
  • RhumbLine Advisers bought 171,799 Medline Inc shares in Q2 2026, an estimated $6.92M.
  • Medline Inc made up 0.01% of RhumbLine Advisers's portfolio in Q2 2026, its #839 holding.
  • RhumbLine Advisers first reported a position in Medline Inc in Q1 2026 and has held it in 2 quarters since.
  • 268 funds tracked by Wall St. Rank held Medline Inc as of Q2 2026.

Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.